Vaxil Bio

(VXLLF)

By |

Profile

Vaxil Bio Ltd is a Canada based immuno-oncology biotechnology company. It is principally engaged in research and development of the ImMucin vaccine to treat cancer. ImMucin is the company's immunotherapy product. The organization is focused on developing novel immunotherapies including neoantigen-like peptide products, and antibodies to treat cancer and infectious diseases. Its VaxHit platform allows identification, isolation, and production of specific antigen-based immunotherapy products.

Contact Information

Website: vxlbio.com
Main Phone: +1 416 227-9667
Address: 4576 Yonge Street
Address 2: 6th Floor
State: ON
City / Town: Toronto
Country: CAN
Postal Code: M2N 6N4

Issuer Information

Exchange: GREY
CEO: Isaac Benjamin Maresky
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.029 $ 0. (0.00%)
Last Price 0.029 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.029 High 0.029 Low 0.029 Prev Close 0.029
Last Trade Volume 4,838 52 Wk Hi 0.19 52 Wk Low 0.0171
Market Cap 2.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 88,929,447.00 EPS (TTM) -0.03 PE Ratio N/A Exchange Greys